Based on the discovery that a CCS/G93A-SOD1 dual transgenic mice model of ALS develop accelerated neurological deficits, consistent with an apparent copper deficiency within the spinal cord, Williams et al. tested a therapeutic approach based on copper replenishment. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.